AVSD - ETF AI Analysis
Top Page
Avantis Responsible International Equity ETF (AVSD)
Rating:65Neutral
Price Target:―
Positive Factors
Broad International Diversification
The fund spreads its investments across many countries, including Japan, the UK, Europe, Canada, and others, which helps reduce the impact of problems in any single market.
Balanced Sector Mix
Holdings are spread across financials, industrials, technology, health care, and consumer sectors, helping avoid heavy dependence on just one part of the economy.
Generally Strong Top Holdings Performance
Most of the largest positions, such as ASML, Celestica, HSBC, and several banks and health care names, have shown strong gains so far this year, supporting the ETF’s overall results.
Negative Factors
Heavy Tilt Toward Financials
Financial companies make up a large share of the portfolio, so the fund could be hit hard if banks and other financial stocks struggle.
Mixed Results Among Top Holdings
A few key positions, including Roche and Toyota, have shown weak performance this year, which can drag on the fund’s returns if the weakness continues.
Moderate Expense Ratio
The fund’s fee is not especially high but is also not among the very cheapest ETFs, slightly reducing the net return investors keep over time.
AVSD vs. SPDR S&P 500 ETF (SPY)
AUM435.40M
RegionDeveloped Markets
Expense Ratio0.23%
Beta0.77
IssuerAvantis
Inception DateMar 15, 2022
Dividend Yield2.5%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume10,255
30 Day Avg. Volume12,864
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
88.19Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering2034
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
AVSD Summary
The Avantis Responsible International Equity ETF (AVSD) is a fund that invests in stocks from many countries outside the U.S., with no single index but a broad “total international market” approach. It focuses on companies that follow responsible and sustainable business practices. Well-known holdings include Toyota Motor and Roche Holding. Investors might consider AVSD to diversify their portfolio globally while aligning with environmental and social values. A key risk is that international stock prices can go up and down with global markets and currency changes, so your investment value may fluctuate.
How much will it cost me?The Avantis Responsible International Equity ETF (AVSD) has an expense ratio of 0.23%, meaning you’ll pay $2.30 per year for every $1,000 invested. This is lower than the average for actively managed ETFs, as AVSD uses a systematic approach to investing rather than frequent trading, which helps keep costs down.
What would affect this ETF?The AVSD ETF, with its focus on developed markets outside the U.S. and strong exposure to sectors like financials and industrials, could benefit from global economic growth and increased demand for sustainable investments. However, it may face challenges from rising interest rates, which could impact financial stocks, and geopolitical tensions or regulatory changes in international markets. Its emphasis on responsible investing aligns with growing investor interest in sustainability, but sector-specific risks, such as technology volatility, could also affect performance.
AVSD Top 10 Holdings
AVSD leans heavily on big international banks and health care giants, with HSBC, Royal Bank of Canada, and Canadian Bank of Commerce all rising and giving the fund a solid financial backbone. On the growth side, ASML and Celestica have been standout winners, adding some high-octane tech flavor to returns. Pharma names like Novartis and GSK are steady climbers, helping smooth out volatility. The main drag comes from Toyota, which has been losing steam lately. Overall, this is a developed-markets, ex-U.S. mix with no single stock dominating, but a clear tilt toward financials and health care.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| HSBC Holdings | 1.08% | $4.72M | $309.74B | 60.93% | 78 Outperform | |
| Roche Holding AG | 1.06% | $4.64M | $329.96B | 30.11% | 73 Outperform | |
| ASML Holding | 1.05% | $4.58M | $546.33B | 110.04% | 81 Outperform | |
| Novartis | 0.86% | $3.76M | $269.97B | 32.66% | 80 Outperform | |
| Celestica | 0.78% | $3.40M | $45.11B | 325.00% | 73 Outperform | |
| Royal Bank Of Canada | 0.76% | $3.32M | $244.23B | 48.64% | 75 Outperform | |
| Vinci SA | 0.67% | $2.92M | €73.15B | 8.40% | 76 Outperform | |
| SoftBank Group | 0.64% | $2.81M | ¥33.32T | 186.72% | 64 Neutral | |
| Canadian Bank of Commerce | 0.62% | $2.71M | C$137.59B | 79.81% | 74 Outperform | |
| GlaxoSmithKline | 0.61% | $2.69M | $111.65B | 48.35% | 77 Outperform |
AVSD Technical Analysis
Positive
―
Price Trends
76.84
Positive
76.18
Positive
72.91
Positive
Market Momentum
0.91
Negative
55.09
Neutral
27.36
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For AVSD, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 76.88, equal to the 50-day MA of 76.84, and equal to the 200-day MA of 72.91, indicating a bullish trend. The MACD of 0.91 indicates Negative momentum. The RSI at 55.09 is Neutral, neither overbought nor oversold. The STOCH value of 27.36 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AVSD.
AVSD Peer Comparison
Comparison Results
Performance Comparison
AVSD
Avantis Responsible International Equity ETF
78.13
17.25
28.33%
FYLD
Cambria Foreign Shareholder Yield ETF
―
―
―
TXUE
Thornburg International Equity ETF
―
―
―
RFDI
First Trust Riverfront Dynamic Developed International ETF
―
―
―
DXIV
Dimensional International Vector Equity ETF
―
―
―
EFFI
Harbor Osmosis International Resource Efficient ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents